Advertisement

Click here for more guidelines.

 
 




CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 1996; 28:1206-1213
© 1996 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bermejo, J
Right arrow Articles by Delcan, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bermejo, J
Right arrow Articles by Delcan, J.

Effects of dobutamine on Doppler echocardiographic indexes of aortic stenosis

J Bermejo, MA Garcia-Fernandez, EG Torrecilla, H Bueno, MM Moreno, D San Roman, and JL Delcan

Department of Cardiology, Hospital General Universitario Gregorio Maranon, Madrid, Spain.

OBJECTIVES: This study sought to assess the diagnostic implications of the flow dependence of Doppler echocardiographic indexes of aortic valve stenosis. BACKGROUND: Although valve area has been shown to change with alterations in flow rate, the diagnostic consequences of this phenomenon remain unknown. Valve resistance has been suggested as a more stable index for evaluating aortic stenosis. METHODS: A low dose dobutamine protocol was performed in 35 patients with aortic stenosis. Hemodynamic indexes were obtained by Doppler echocardiography at baseline and at each dobutamine dose. RESULTS: As a result of the shortening of the systolic ejection period, flow increased from (mean +/- SD) 164 +/- 48 to 229 +/- 102 ml/s (p < 0.0001). At peak flow, valve area increased by 28% (from 0.5 +/- 0.2 to 0.6 +/- 0.3 cm2, p < 0.0001), whereas valve resistance decreased by 4% (from 498 +/- 252 to 459 +/- 222 dynes.s.cm-5, p = 0.04). This observed change in resistance was smaller than that for valve area (p < 0.01). The flow dependence of valve area varied among individual patients (p < 0.0001). Multivariate analysis identified calcific degenerative etiology (beta 0.29, p = 0.002), left ventricular velocity of fiber shortening (beta 0.22, p = 0.01), baseline flow (beta -0.28, p = 0.04) and amount of flow increased induced by dobutamine (beta 0.90, p < 0.0001) as factors related to valve area flow dependence. CONCLUSIONS: Although all Doppler echocardiographic indexes of aortic stenosis are affected by flow, valve resistance is more stable than valve area under dobutamine-induced hemodynamic changes. Baseline valve area may be unreliable in patients with calcific degenerative aortic stenosis and low output states.


This article has been cited by other articles:


Home page
Eur Heart J Cardiovasc ImagingHome page
H. Baumgartner, J. Hung, J. Bermejo, J. B. Chambers, A. Evangelista, B. P. Griffin, B. Iung, C. M. Otto, P. A. Pellikka, and M. Quinones
Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice
Eur Heart J Cardiovasc Imaging, January 1, 2009; 10(1): 1 - 25.
[Full Text] [PDF]


Home page
CirculationHome page
2006 WRITING COMMITTEE MEMBERS, R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, et al.
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
Circulation, October 7, 2008; 118(15): e523 - e661.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al.
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
J. Am. Coll. Cardiol., September 23, 2008; 52(13): e1 - e142.
[Full Text] [PDF]


Home page
Eur Heart JHome page
J. Mascherbauer, C. Fuchs, M. Stoiber, H. Schima, E. Pernicka, G. Maurer, and H. Baumgartner
Systemic pressure does not directly affect pressure gradient and valve area estimates in aortic stenosis in vitro
Eur. Heart J., August 2, 2008; 29(16): 2049 - 2057.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J Cardiovasc ImagingHome page
R. Sicari, P. Nihoyannopoulos, A. Evangelista, J. Kasprzak, P. Lancellotti, D. Poldermans, J.-U. Voigt, J. L. Zamorano, and on behalf of the European Association of Echocardi
Stress echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC)
Eur Heart J Cardiovasc Imaging, July 1, 2008; 9(4): 415 - 437.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
S. H Little, K.-L. Chan, and I. G Burwash
Impact of blood pressure on the Doppler echocardiographic assessment of severity of aortic stenosis
Heart, July 1, 2007; 93(7): 848 - 855.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
J Bermejo and R Yotti
Low-gradient aortic valve stenosis: value and limitations of dobutamine stress testing
Heart, March 1, 2007; 93(3): 298 - 302.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al.
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons
J. Am. Coll. Cardiol., August 1, 2006; 48(3): e1 - e148.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al.
ACC/AHA 2006 Practice Guidelines for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons
J. Am. Coll. Cardiol., August 1, 2006; 48(3): 598 - 675.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
L. Kadem, R. Rieu, J. G. Dumesnil, L.-G. Durand, and P. Pibarot
Flow-Dependent Changes in Doppler-Derived Aortic Valve Effective Orifice Area Are Real and Not Due to Artifact
J. Am. Coll. Cardiol., January 3, 2006; 47(1): 131 - 137.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
L. Kadem, R. Rieu, J. G. Dumesnil, L.-G. Durand, and P. Pibarot
Flow-Dependent Changes in Doppler-Derived Aortic Valve Effective Orifice Area Are Real and Not Due to Artifact
J. Am. Coll. Cardiol., December 14, 2005; (2005) j.jacc.2005.05.100v1.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
J Jimenez-Candil, J Bermejo, R Yotti, C Cortina, M Moreno, J L Cantalapiedra, and M A Garcia-Fernandez
Effects of angiotensin converting enzyme inhibitors in hypertensive patients with aortic valve stenosis: a drug withdrawal study
Heart, October 1, 2005; 91(10): 1311 - 1318.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
J Bermejo
The effects of hypertension on aortic valve stenosis
Heart, March 1, 2005; 91(3): 280 - 282.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
J. Mascherbauer, H. Schima, R. Rosenhek, M. Czerny, G. Maurer, and H. Baumgartner
Value and limitations of aortic valve resistance with particular consideration of low flow-low gradient aortic stenosis: an in vitro study
Eur. Heart J., May 1, 2004; 25(9): 787 - 793.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. Weerasinghe, M. Yusuf, T. Athanasiou, A. Wood, P. Magee, and R. Uppal
Role of transvalvular gradient in outcome from valve replacement for aortic stenosis
Ann. Thorac. Surg., April 1, 2004; 77(4): 1266 - 1271.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
D. Messika-Zeitoun, S. Fung Yiu, B. Cormier, B. Iung, C. Scott, A. Vahanian, A Jamil Tajik, and M. Enriquez-Sarano
Sequential assessment of mitral valve area during diastole using colour M-mode flow convergence analysis: new insights into mitral stenosis physiology
Eur. Heart J., July 1, 2003; 24(13): 1244 - 1253.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
P. Das, H. Rimington, N. Smeeton, and J. Chambers
Determinants of symptoms and exercise capacity in aortic stenosis: a comparison of resting haemodynamics and valve compliance during dobutamine stress
Eur. Heart J., July 1, 2003; 24(13): 1254 - 1263.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. Bermejo, R. Odreman, J. Feijoo, M. M. Moreno, P. Gomez-Moreno, and M. A. Garcia-Fernandez
Clinical efficacy of Doppler-echocardiographic indices of aortic valve stenosis:a comparative test-based analysis of outcome
J. Am. Coll. Cardiol., January 1, 2003; 41(1): 142 - 151.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J.-L. Monin, M. Monchi, V. Gest, A.-M. Duval-Moulin, J.-L. Dubois-Rande, and P. Gueret
Aortic stenosis with severe left ventricular dysfunction and low transvalvular pressure gradients: Risk stratification by low-dose dobutamine echocardiography
J. Am. Coll. Cardiol., June 15, 2001; 37(8): 2101 - 2107.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
E. Schwammenthal, Z. Vered, Y. Moshkowitz, B. Rabinowitz, Z. Ziskind, A. K. Smolinski, and M. S. Feinberg
Dobutamine Echocardiography in Patients With Aortic Stenosis and Left Ventricular Dysfunction : Predicting Outcome as a Function of Management Strategy
Chest, June 1, 2001; 119(6): 1766 - 1777.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
F ANTONINI-CANTERIN, P FAGGIANO, D ZANUTTINI, and F RIBICHINI
Is aortic valve resistance more clinically meaningful than valve area in aortic stenosis?
Heart, July 1, 1999; 82(1): 9 - 10.
[Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement